Antipsychotics: is it time to introduce patient choice?

被引:80
作者
Morrison, Anthony P. [1 ,2 ]
Hutton, Paul [3 ]
Shiers, David
Turkington, Douglas [4 ,5 ]
机构
[1] Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England
[2] Greater Manchester W Natl Hlth Serv NHS Mental Hl, Manchester, Lancs, England
[3] Greater Manchester W NHS Mental Hlth Fdn Trust, Manchester, Lancs, England
[4] Northumberland Tyne & Wear NHS Mental Hlth Fdn Tr, Newcastle Upon Tyne, Tyne & Wear, England
[5] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
D O I
10.1192/bjp.bp.112.112110
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Evidence regarding overestimation of the efficacy of antipsychotics and underestimation of their toxicity, as well as emerging data regarding alternative treatment options, suggests it may be time to introduce patient choice and reconsider whether everyone who meets the criteria for a schizophrenia spectrum diagnosis requires antipsychotics in order to recover.
引用
收藏
页码:83 / 84
页数:2
相关论文
共 15 条
  • [1] Non-pharmacological management of anti psychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials
    Alvarez-Jimenez, Mario
    Hetrick, Sarah E.
    Gonzalez-Blanch, Cesar
    Gleeson, John F.
    McGorry, Patrick D.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2008, 193 (02) : 101 - 107
  • [2] Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers
    Artaloytia, JF
    Arango, C
    Lahti, A
    Sanz, J
    Pascual, A
    Cubero, P
    Prieto, D
    Palomo, T
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (03) : 488 - 493
  • [3] Attitudes toward antipsychotic medication - The impact of clinical variables and relationships with health professionals
    Day, JC
    Bentall, RP
    Roberts, C
    Randall, F
    Rogers, A
    Cattell, D
    Healy, D
    Rae, P
    Power, C
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (07) : 717 - 724
  • [4] Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
    Foley, Debra L.
    Morley, Katherine I.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2011, 68 (06) : 609 - 616
  • [5] Harrow M., 2012, Psychol Med, P1
  • [6] Clinical relevance of findings in trials of antipsychotics: systematic review
    Lepping, Peter
    Sambhi, Rajvinder S.
    Whittington, Richard
    Lane, Steven
    Poole, Rob
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2011, 198 (05) : 341 - 345
  • [7] How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
    Leucht, S.
    Arbter, D.
    Engel, R. R.
    Kissling, W.
    Davis, J. M.
    [J]. MOLECULAR PSYCHIATRY, 2009, 14 (04) : 429 - 447
  • [8] Linking the PANSS, BPRS, and CGI: Clinical implications
    Leucht, Stefan
    Kane, John M.
    Etschel, Eva
    Kissling, Werner
    Hamann, Johannes
    Engel, Rolf R.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 (10) : 2318 - 2325
  • [9] Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
    Leucht, Stefan
    Corves, Caroline
    Arbter, Dieter
    Engel, Rolf R.
    Li, Chunbo
    Davis, John M.
    [J]. LANCET, 2009, 373 (9657) : 31 - 41
  • [10] The different trajectories of antipsychotic response: antipsychotics versus placebo
    Marques, T. R.
    Arenovich, T.
    Agid, O.
    Sajeev, G.
    Muthen, B.
    Chen, L.
    Kinon, B. J.
    Kapur, S.
    [J]. PSYCHOLOGICAL MEDICINE, 2011, 41 (07) : 1481 - 1488